Medtronic Evolut

Medtronic PLC (NYSE:MDT) Soars With The Approva...

Medtronic launches off two new studies evaluati...

Excellent outcomes for Medtronic Evolut TAVR in...

Medtronic Vascular, D-EVPROP2329US, Medtronic E...

Medtronic begins SMART trial, and feasility stu...

Medtronic announces FDA approval of newest-gene...

Medtronic Vascular D-EVOLUTFX-2329 box of 1... ...

Medtronic Cardiac and Vascular on LinkedIn: 🔎 ...

TAVI: Medtronic launches U.S. trial for CoreVal...

Medtronic gets expanded CE mark for Evolut TAVI...

SMART trial one-year data demonstrates Medtroni...

Medtronic wins CE mark for Evolut TAVR system i...

Medtronic has positive Evolut TAVR data

FDA approves revised labelling for Medtronic’s ...

Medtronic Cardiac and Vascular on LinkedIn: Pat...

Medtronic Cardiac and Vascular on LinkedIn: Evo...

CIS & Terrebonne General are First in Louisiana...

Medtronic Cardiac and Vascular on LinkedIn: Evo...

Medtronic Cardiac and Vascular on LinkedIn: Evo...

Medtronic - Evolut R System Transcatheter Aorti...

Study: Medtronic Evolut TAVR Platform Outperfor...

Medtronic News - Business & regional news

New MEDTRONIC D-EVOLUTFX-2329 Evolut FX Deliver...

Medtronic secures CE mark for Evolut FX TAVI sy...

Medtronic - Evolut R System Transcatheter Aorti...

Medtronic - Evolut R System Transcatheter Aorti...

Medtronic wins expanded CE Mark for Evolut R TA...

Medtronic launches new Evolut TAVR System in US

Medtronic Timeline

Complete Two-Year Data Confirms That Medtronic'...

Medtronic announces FDA approval of newest-gene...

Medtronic Cardiac and Vascular on LinkedIn: Key...

TAVI: FDA approves Medtronic's CoreValve Evolut...

Medtronic Timeline

Medtronic Cardiac and Vascular on LinkedIn: Evo...